Successful Trials Prove That Multiple Sclerosis Will Soon Be Curable
Clinical trials have shown that researchers may have finally found a breakthrough in fighting relapsing-remitting multiple sclerosis (MS). The medication consists of a high dose immunosuppressive therapy combined with an implant of the patient’s blood-forming stem cells.
This therapy has demonstrated that it can slacken the effects of MS, a condition which causes the immune system to attack the neural system.
69% of patients who tried the new drug have lived on without experiencing new MS symptoms, brain complications or advancement of neurological disability. The remedy, called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT) has recorded a greater success rate than all of its challengers in the market.
The study was conducted by the National Institute of Allergy and Infectious Diseases (NIAID). The volunteers, MS patients aged 26 to 52, had reported that other treatments they were taking had side effects.
However, the use of HDIT/HCT proved to be safe and efficient.
The drug reduces the disease by eliminating the infected cells from the immune system. Doctors extract stem cells while administering the high dose therapy to suppress the immune system. The stem cells are the implanted back into the patient to reconstruct the immune system.
Patients showed tremendous improvements five years after taking the medication. Scholars aim to re-conduct the trial using a larger sample to increase the medication’s credibility. Although the therapy is still in its early stages, it has shown the proverbial light at the end of the tunnel in the fight against MS.
Dr. Shiva’s Background
Dr. Shiva Gopal Vasishta is a neurologist based in Voorhees, New Jersey. He boasts of vast experience in the field, having practiced for almost four decades. He graduated from Government Medical College in 1979.
Shiva Gopal Vasishta is an adherent of Medicare program hence he does not charge more than the approved amount if you are a Medicare member.
Additionally, Dr. Shiva Gopal Vasishta is an active associate of the American board of psychiatry and neurology.